Navigation Links
New strategy likely to speed drug development for rare cancers
Date:9/15/2011

Researchers have identified promising new therapies for ependymoma, a rare tumor with few treatment options. St. Jude Children's Research Hospital investigators led the effort, which used a new, faster drug development system that combines the latest drug screening technology with the first accurate animal model of the tumor.

Investigators identified several dozen new and existing drugs as possible ependymoma treatment candidates. The drugs were found by screening 5,303 existing medicines, natural products and other compounds for activity against the tumor, which develops in the brain and spine of children and adults. The work is published in the current edition of the scientific journal Cancer Cell.

The list of candidate drugs included 5-fluorouracil (5-FU). 5-FU has been widely used to treat a variety of adult cancers but has not been formally tested against ependymoma. Based on study results, St. Jude is planning a clinical trial of 5-FU in young ependymoma patients, said senior author Richard Gilbertson, M.D., Ph.D., director of the St. Jude Comprehensive Cancer Center. Gilbertson credited the method used in this study with highlighting 5-FU's potential.

Researchers hope to use the same system to expand chemotherapy options for patients with other cancers. "This approach should significantly advance the efficiency and speed with which we discover and develop new treatments for rare cancers and cancer subtypes," the investigators noted. Jennifer Atkinson, Ph.D., a former St. Jude postdoctoral fellow, is the first author. R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics, and Gilbertson are corresponding authors.

Rather than waiting years for clinical trial results, this system promises to take just months to provide key information about a drug's effectiveness and optimal administration, Gilbertson said.

The results are good news for patients with ependymoma and ot
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study points to strategy for overcoming resistance to targeted cancer drug
2. Research identifies marketing mix strategy for pharmaceutical firms
3. New Strategy Trains All Soldiers in Trauma Care
4. NIH supports new research strategy for finding a cure for HIV
5. Coping Strategy Depends on Strength of Emotion: Study
6. Innovative duct tape strategy saves hospitals time, money; improves infection prevention
7. New strategy to attack tumor-feeding blood vessels
8. Researchers develop strategy to improve patient adherence
9. Potential new strategy to reduce catheter blockage
10. A Pacman strategy to boost the immune system to fight cancer
11. Scientists devise targeted therapy strategy for rare form of childhood cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... elderly American adults is being financially exploited often ... crisis especially affects poor and black people. It merits ... citizen who cares about the dignity and well-being of ... Medical College in the US. She led one of ... findings of which appear in the Journal of ...
(Date:7/30/2014)... hospital in Ireland has shown than many of them did ... the risk of entrapment. The report, published online in the ... for careful selection of patients for whom bedrails are to ... maintenance of hospital bed systems. , Bedrails are commonly used ... although the risk for any individual is extremely low, people ...
(Date:7/30/2014)... The report entitled “Global Pulse Oximetry Market: Trends ... dynamics and changing trends in the global pulse oximetry ... sizing of the global pulse oximetry market and also ... same. It further captures the global market share based ... Further, the report discusses the domestic market of United ...
(Date:7/30/2014)... Los Angeles cosmetic dentist , ... that can help patients create their dream smiles at ... gums form the foundation of smile confidence, but cosmetic ... misshapen teeth or stains may not interfere with dental ... The right cosmetic treatments can eliminate chips, erase stains ...
(Date:7/30/2014)... July 30, 2014 Building ENT and ... allergy, and audiology practice in Westchester County takes the ... technology, a superb underlying corporate structure and protocols, and ... also takes a leading Chief Financial Officer to help ... (WCBJ), that’s exactly what it possesses. In fact, in ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3
... BAYFIELD, Colo., July 14 Kanakuk Colorado today released the ... illness. , , "Yesterday, Kanakuk ... that at 2:00 p.m. on Saturday afternoon 2 campers presented to ... throats. Within 30 minutes these campers had been isolated from the ...
... , , , ... an older adult can easily turn into a downward slide into a ... health care for the elderly, Aurora Health Care is sponsoring a continuing ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
... BINGHAM FARMS, Mich., July 14 United Physicians ... 1st, 2009. The decision to take a more eco-friendly ... faxes that have historically been used to communicate with the ... "The decision to ,Go Green, with our business communications ...
... HAYWARD, Calif., July 14 Solta Medical, Inc. (Nasdaq: ... today announced that it will release its financial results for the ... Thursday, July 30, 2009. The Company will also host a ... p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results ...
... MIAMI and SAN DIEGO, July 14 Sorrento ... for the generation of fully human monoclonal antibodies, and QuikByte ... no active operations, have signed a merger agreement pursuant to ... QuikByte. After the merger is completed, QuikByte will be ...
... compliance, study finds , TUESDAY, July 14 (HealthDay News) -- ... use of a reminder program for women who were due ... Permanente staff checked electronic health records of its 35,000 members ... a mammogram for 20 months. They were sent a postcard ...
Cached Medicine News:Health News:Statement for Attribution to Andy Braner, President, Kanakuk Colorado, Bayfield CO 2Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 2Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 3Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 4Health News:United Physicians Goes Green Effective August 1st, 2009 2Health News:Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 3Health News:Reminders Boost Mammography Appointments 2
(Date:7/30/2014)... -- Hospira, Inc. (NYSE: HSP ), the ... technologies, today reported results for the second quarter ... quarter were $1.1 billion and adjusted* diluted earnings ... items as described later in this press release ... Accepted Accounting Principles (GAAP) basis, second-quarter 2014 diluted ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014 /PRNewswire/ ... held biotech company that designs and develops novel ... management of cancer, announced today the completion of ... The financing included new investors RusnanoMedInvest (RMI) and ... Fund, and Pfizer Venture Investments, as well as ...
(Date:7/30/2014)... 30. Juli 2014 Die Apex ... Anbieter im Bereich Atemtherapie- und Druckzonenprodukte, gibt ... München in Deutschland anfechten werden. Dieses hat ... ein Patent von ResMed verletze. Apex weist ... Ländern gegen verschiedene Patente von ResMed Anfechtungen ...
Breaking Medicine Technology:Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3
... Sept. 23 Surefil, a contract manufacturer of liquid-fill ... medical industries, and energy drinks, emerged from Chapter 11 ... The company was able to attract ABACO Partners, LLC ... Executive Officer of Universal Forest Products, Bill Currie, to ...
... Netherlands, Sept. 23 DuPont (NYSE: DD ... form a joint venture to develop, manufacture and commercialize ... The joint venture will be named Actamax Surgical Materials ... will each share a 50 percent interest. The ...
Cached Medicine Technology:Surefil Emerges from Chapter 11 2DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 2DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 3DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 4
... bench style refrigerator (can be situated on or ... of bags is to be stored as in ... white colorbond steel while the interior is a ... door is key lockable. Control panel is flush ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... This HPLC for Vitamin B6 makes ... an easy, fast and precise method. The ... form for preparation and separation of the ... of HPLC analytics is the simultaneous handling ...
Medicine Products: